M MiddleBrook Pharmaceuticals
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) (formerly Advancis) is a pharmaceutical company focused on developing and commercializing anti-infective products that fulfill unmet medical needs. MiddleBrook currently markets KEFLEX®, the immediate-release brand of cephalexin, and MOXATAG® - the first and only FDA-approved once-daily amoxicillin.
About MiddleBrook Pharmaceuticals
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) (formerly Advancis) is a pharmaceutical company focused on developing and commercializing anti-infective products that fulfill unmet medical needs. MiddleBrook currently markets KEFLEX®, the immediate-release brand of cephalexin, and MOXATAG® - the first and only FDA-approved once-daily amoxicillin.
Social Media
Frequently Asked Questions
What does MiddleBrook Pharmaceuticals do?
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) (formerly Advancis) is a pharmaceutical company focused on developing and commercializing anti-infective products that fulfill unmet medical needs. MiddleBrook currently markets KEFLEX®, the immediate-release brand of cephalexin, and MOXATAG® - the first and only FDA-approved once-daily amoxicillin.
How can I contact MiddleBrook Pharmaceuticals?
Visit their website at middlebrookpharma.com for more information.
Where is MiddleBrook Pharmaceuticals located?
Trophy Club, United States
What industry is MiddleBrook Pharmaceuticals in?
pharmaceuticals
How many employees does MiddleBrook Pharmaceuticals have?
10-50
When was MiddleBrook Pharmaceuticals founded?
2000
Looking for More Company Information?
Discover more innovative companies in our comprehensive directory.
Browse All Companies